Connacht Asset Management LP Abb Vie Inc. Transaction History

Connacht Asset Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $217,285 - $249,212	-1,619 Reduced 13.51%	10,366 $1.39 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $635,942 - $808,490	4,621 Added 62.75%	11,985 $1.84 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $971,900 - $1.21 Million	7,364 New	7,364 $1.19 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Connacht Asset Management LP, based on Form 13F filings with the SEC.

Stay updated on Connacht Asset Management LP with notifications on news.